{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Diabetes mellitus", "HbA1c", "Ozone therapy", "Visual evoked potentials"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37365632", "DateRevised": {"Year": "2023", "Month": "07", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "06", "Day": "26"}], "ELocationID": ["140", "10.1186/s13098-023-01114-w"], "Journal": {"ISSN": "1758-5996", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "26"}}, "Title": "Diabetology & metabolic syndrome", "ISOAbbreviation": "Diabetol Metab Syndr"}, "ArticleTitle": "Efficacy of ozone therapy on visual evoked potentials in diabetic patients.", "Pagination": {"StartPage": "140", "MedlinePgn": "140"}, "Abstract": {"AbstractText": ["The involvement of the central nervous system is a frequent yet underestimated complication of diabetes mellitus. Visual evoked potentials (VEP) are a simple, sensitive, and noninvasive method for detecting early alterations in central optic pathways. The objective of this paralleled randomized controlled trial was to evaluate the impact of ozone therapy on visual pathways in diabetic patients.", "Sixty patients with type 2 diabetes visiting clinics of Baqiyatallah university\u00a0in Tehran\u00a0(Iran) hospital were randomly assigned to two experimental groups: Group 1 (N\u2009=\u200930) undergoing a cycle of 20 sessions of systemic oxygen-ozone therapy in addition to standard therapy for metabolic control; Group 2 (N\u2009=\u200930)-serving as control-receiving\u00a0only standard therapy against diabetes. The primary study endpoints were two VEP parameters; P100 wave latency and P100 amplitude\u00a0at\u00a03 months. Moreover,\u00a0HbA<sub>1c</sub> levels were measured before the start of treatment and three months later as secondary study endpoint.", "All 60 patients completed the clinical trial. P100 latency significantly reduced at 3\u00a0months since baseline. No correlation was found between repeated measures of P100 wave latency and HbA<sub>1c</sub> (Pearson's r\u2009=\u20090.169, p\u2009=\u20090.291). There was no significant difference between baseline values\u00a0and repeated measures of P100 wave amplitude over time\u00a0in either group. No adverse effects were recorded.", "Ozone therapy improved the conduction of impulses in optic pathways of diabetic patients. The improved glycemic control following ozone therpay may not fully explain the reduction of P100 wave latency though; other mechanistic effects of ozone may be involved."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Izadi", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Clinical Science Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. mhmjvbt81@gmail.com."}], "LastName": "Javanbakht", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biostatistics, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Ali_sh_1993@yahoo.com."}], "LastName": "Sarafzadeh", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology and Urology Research Center, Clinical Science Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Einollahi", "ForeName": "Behzad", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology Department, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Futuhi", "ForeName": "Farzaneh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatrics, School of Medicine, Hazrat-E Ali. Asghar Pediatrics Hospital, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Vahedi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Zhao", "ForeName": "Shi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Jonaidi-Jafari", "ForeName": "Nematollah", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Hosseini", "ForeName": "Mahboobeh Sadat", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Nejad", "ForeName": "Javad Hosseini", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Department, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Naeimi", "ForeName": "Effat", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Behavioral Sciences Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Saadat", "ForeName": "Seyed Hassan", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Ghaleh", "ForeName": "Hadi Esmaeili Gouvarchin", "Initials": "HEG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ozone CRC, BMSU, Tehran, Iran."}], "LastName": "Fazel", "ForeName": "Mozhgan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nephrology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Einollahi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical, Surgical & Health Sciences, University of Trieste, Trieste, Italy."}, {"Identifier": [], "Affiliation": "Occupational Medicine Unit, University Health Agency Giuliano-ISontina (ASUGI), Trieste, Italy."}], "LastName": "Cegolon", "ForeName": "Luca", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Diabetol Metab Syndr", "NlmUniqueID": "101488958", "ISSNLinking": "1758-5996"}, "CommentsCorrectionsList": [{"RefSource": "Diabetol Metab Syndr. 2023 Jul 7;15(1):153. doi: 10.1186/s13098-023-01127-5", "PMID": "37415225"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, IDF Diabetes Atlas Committee Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison\u2019s principles of internal medicine 19th edition and Harrison\u2019s manual of medicine 19th edition (EBook)VAL PAK. New York: McGraw-Hill Education; 2017."}, {"Citation": "Raman P, Sodani A, George B. A study of visual evoked potential changes in diabetes mellitus. Int J Diabetes Dev Ctries. 1997;17:69\u201373."}, {"Citation": "V\u00e1rkonyi TT, Pet\u00f5 T, D\u00e9gi R, Keresztes K, Lengyel C, Jan\u00e1ky M, Kempler P, Lonovics J. Impairment of visual evoked potentials: an early central manifestation of diabetic neuropathy? Diabetes Care. 2002;25(9):1661\u20131662. doi: 10.2337/diacare.25.9.1661.", "ArticleIdList": ["10.2337/diacare.25.9.1661", "12196448"]}, {"Citation": "Goldenberg Z, Kucera P, Brezinova M, Kurca E, Barak L, Traubner P. Clinically unapparent central motor pathways lesion in patients with type I diabetes mellitus. A transcranial magnetic stimulation study. Bratisl Lek Listy. 2004;105(12):400\u2013403.", "ArticleIdList": ["15777068"]}, {"Citation": "Suzuki C, Ozaki I, Tanosaki M, Suda T, Baba M, Matsunaga M. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology. 2000;54(10):1932\u20131937. doi: 10.1212/WNL.54.10.1932.", "ArticleIdList": ["10.1212/WNL.54.10.1932", "10822432"]}, {"Citation": "Mooradian AD. Central nervous system complications of diabetes mellitus\u2014a perspective from the blood\u2013brain barrier. Brain Res Brain Res Rev. 1997;23(3):210\u2013218. doi: 10.1016/S0165-0173(97)00003-9.", "ArticleIdList": ["10.1016/S0165-0173(97)00003-9", "9164671"]}, {"Citation": "Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586(18):4401\u20134408. doi: 10.1113/jphysiol.2008.156695.", "ArticleIdList": ["10.1113/jphysiol.2008.156695", "PMC2614025", "18565995"]}, {"Citation": "Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev. 1994;10(3):189\u2013224. doi: 10.1002/dmr.5610100302.", "ArticleIdList": ["10.1002/dmr.5610100302", "7835170"]}, {"Citation": "Ceriello A. New insights on oxidative stress and diabetic complications may lead to a \u201ccausal\u201d antioxidant therapy. Diabetes Care. 2003;26(5):1589\u20131596. doi: 10.2337/diacare.26.5.1589.", "ArticleIdList": ["10.2337/diacare.26.5.1589", "12716823"]}, {"Citation": "Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u20131625. doi: 10.2337/diabetes.54.6.1615.", "ArticleIdList": ["10.2337/diabetes.54.6.1615", "15919781"]}, {"Citation": "Low PA, Lagerlund TD, McManis PG. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol. 1989;31:355\u2013438. doi: 10.1016/S0074-7742(08)60283-4.", "ArticleIdList": ["10.1016/S0074-7742(08)60283-4", "2557297"]}, {"Citation": "Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301\u2013314. doi: 10.1007/s11154-008-9104-2.", "ArticleIdList": ["10.1007/s11154-008-9104-2", "PMC4239697", "18709457"]}, {"Citation": "Obrosova IG, Fathallah L, Stevens MJ. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol. 2001;172(1):211\u2013219. doi: 10.1006/exnr.2001.7789.", "ArticleIdList": ["10.1006/exnr.2001.7789", "11681853"]}, {"Citation": "Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973\u20131988. doi: 10.1007/s001250100001.", "ArticleIdList": ["10.1007/s001250100001", "11719828"]}, {"Citation": "Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig. 2011;2(1):18\u201332. doi: 10.1111/j.2040-1124.2010.00070.x.", "ArticleIdList": ["10.1111/j.2040-1124.2010.00070.x", "PMC4008011", "24843457"]}, {"Citation": "Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 1997;46(Suppl 2):S38\u201342. doi: 10.2337/diab.46.2.S38.", "ArticleIdList": ["10.2337/diab.46.2.S38", "9285497"]}, {"Citation": "Tomlinson DR. Future prevention and treatment of diabetic neuropathy. Diabetes Metab. 1998;24(Suppl 3):79\u201383.", "ArticleIdList": ["9881237"]}, {"Citation": "Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 1997;46(Suppl 2):S31\u2013S37. doi: 10.2337/diab.46.2.S31.", "ArticleIdList": ["10.2337/diab.46.2.S31", "9285496"]}, {"Citation": "Van Dam PS, Bravenboer B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun. 1997;21(1):41\u201348. doi: 10.1002/(SICI)1520-6769(199707)21:1<41::AID-NRC206>3.0.CO;2-J.", "ArticleIdList": ["10.1002/(SICI)1520-6769(199707)21:1<41::AID-NRC206>3.0.CO;2-J"]}, {"Citation": "Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol. 1999;375(1\u20133):217\u2013223. doi: 10.1016/S0014-2999(99)00356-8.", "ArticleIdList": ["10.1016/S0014-2999(99)00356-8", "10443578"]}, {"Citation": "Hazucha MJ, Bates DV, Bromberg PA. Mechanism of action of ozone on the human lung. J Appl Physiol. 1989;67(4):1535\u20131541. doi: 10.1152/jappl.1989.67.4.1535.", "ArticleIdList": ["10.1152/jappl.1989.67.4.1535", "2793755"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29(4):646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Bocci V, Zanardi I, Huijberts MS, Travagli V. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes Metab Syndr. 2011;5(1):45\u201349. doi: 10.1016/j.dsx.2010.05.014.", "ArticleIdList": ["10.1016/j.dsx.2010.05.014", "22814842"]}, {"Citation": "Bocci V. Is it true that ozone is always toxic? The end of a dogma. Toxicol Appl Pharmacol. 2006;216(3):493\u2013504. doi: 10.1016/j.taap.2006.06.009.", "ArticleIdList": ["10.1016/j.taap.2006.06.009", "16890971"]}, {"Citation": "Izadi M, Cegolon L, Javanbakht M, Sarafzadeh A, Abolghasemi H, Alishiri G, Zhao S, Einollahi B, Kashaki M, Jonaidi-Jafari N, Asadi M, Jafari R, Fathi S, Nikoueinejad H, Ebrahimi M, Imanizadeh S, Ghazale AH. Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review. Int Immunopharmacol. 2021;92:107307. doi: 10.1016/j.intimp.2020.107307.", "ArticleIdList": ["10.1016/j.intimp.2020.107307", "PMC7752030", "33476982"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Al-Dalain SM, Men\u00e9ndez S, et al. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523(1\u20133):151\u2013161. doi: 10.1016/j.ejphar.2005.08.020.", "ArticleIdList": ["10.1016/j.ejphar.2005.08.020", "16198334"]}, {"Citation": "Delgado-Roche L, Riera-Romo M, Mesta F, et al. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur J Pharmacol. 2017;811:148\u2013154. doi: 10.1016/j.ejphar.2017.06.017.", "ArticleIdList": ["10.1016/j.ejphar.2017.06.017", "28623000"]}, {"Citation": "Algan M, Ziegler O, Gehin P, et al. Visual evoked potentials in diabetic patients. Diabetes Care. 1989;12(3):227\u2013229. doi: 10.2337/diacare.12.3.227.", "ArticleIdList": ["10.2337/diacare.12.3.227", "2702915"]}, {"Citation": "Wysocka-Mincewicz M, Trippenbach-Dulska H, Emeryk-Szajewska B, Zakrzewska-Pniewska B, Kochanek K, Pa\u0144kowska E. Co-existence of abnormalities in the peripheral nervous system and in the auditory and visual evoked potentials in children with type 1 diabetes. Diabetologia Doswiadczalna i Kliniczna. 2007;7(1):44\u201349."}, {"Citation": "Antal A, Kincses TZ, Nitsche MA, Bartfai O, Paulus W. Excitability changes induced in the human primary visual cortex by transcranial direct current stimulation: direct electrophysiological evidence. Invest Ophthalmol Vis Sci. 2004;45(2):702\u2013707. doi: 10.1167/iovs.03-0688.", "ArticleIdList": ["10.1167/iovs.03-0688", "14744917"]}, {"Citation": "Moreo G, Mariani E, Pizzamiglio G, Colucci GB. Visual evoked potentials in NIDDM: a longitudinal study. Diabetologia. 1995;38(5):573\u2013576. doi: 10.1007/BF00400726.", "ArticleIdList": ["10.1007/BF00400726", "7489840"]}, {"Citation": "Mariani E, Moreo G, Colucci GB. Study of visual evoked potentials in diabetics without retinopathy: correlations with clinical findings and polyneuropathy. Acta Neurol Scand. 1990;81(4):337\u2013340. doi: 10.1111/j.1600-0404.1990.tb01566.x.", "ArticleIdList": ["10.1111/j.1600-0404.1990.tb01566.x", "2360401"]}, {"Citation": "Verrotti A, Lobefalo L, Trotta D, et al. Visual evoked potentials in young persons with newly diagnosed diabetes: a long-term follow-up. Dev Med Child Neurol. 2000;42(4):240\u2013244. doi: 10.1017/S0012162200000414.", "ArticleIdList": ["10.1017/S0012162200000414", "10795562"]}, {"Citation": "Puvanendran K, Devathasan G, Wong PK. Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry. 1983;46(7):643\u2013647. doi: 10.1136/jnnp.46.7.643.", "ArticleIdList": ["10.1136/jnnp.46.7.643", "PMC1027484", "6886702"]}, {"Citation": "Seidl R, Birnbacher R, Hauser E, Bernert G, Freilinger M, Schober E. Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM. Diabetes Care. 1996;19(11):1220\u20131224. doi: 10.2337/diacare.19.11.1220.", "ArticleIdList": ["10.2337/diacare.19.11.1220", "8908383"]}, {"Citation": "Anastasi M, Lauricella M, Giordano C, Galluzzo A. Visual evoked potentials in insulin-dependent diabetics. Acta Diabetol Lat. 1985;22(4):343\u2013349. doi: 10.1007/BF02624753.", "ArticleIdList": ["10.1007/BF02624753", "3832707"]}, {"Citation": "Ziegler O, Guerci B, Algan M, Lonchamp P, Weber M, Drouin P. Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic control. Diabetes Care. 1994;17(10):1141\u20131147. doi: 10.2337/diacare.17.10.1141.", "ArticleIdList": ["10.2337/diacare.17.10.1141", "7821133"]}, {"Citation": "Khardori R, Soler NG, Good DC, DevlescHoward AB, Broughton D, Walbert J. Brainstem auditory and visual evoked potentials in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1986;29(6):362\u2013365. doi: 10.1007/BF00903345.", "ArticleIdList": ["10.1007/BF00903345", "3743921"]}, {"Citation": "Yaltkaya K, Balkan S, Baysal AI. Visual evoked potentials in diabetes mellitus. Acta Neurol Scand. 1988;77(3):239\u2013241. doi: 10.1111/j.1600-0404.1988.tb05902.x.", "ArticleIdList": ["10.1111/j.1600-0404.1988.tb05902.x", "3376748"]}, {"Citation": "Heravian J, Ehyaei A, Shoeibi N, et al. Pattern visual evoked potentials in patients with type II diabetes mellitus. J Ophthalmic Vis Res. 2012;7(3):225\u2013230.", "ArticleIdList": ["PMC3520591", "23264865"]}, {"Citation": "Pescosolido N, Barbato A, Stefanucci A, Buomprisco G. Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy. J Diabetes Res. 2015;2015:319692. doi: 10.1155/2015/319692.", "ArticleIdList": ["10.1155/2015/319692", "PMC4436463", "26075282"]}, {"Citation": "American Clinical Neurophysiology Society Guideline 5: guidelines for standard electrode position nomenclature. J Clin Neurophysiol. 2006;23(2):107\u2013110. doi: 10.1097/00004691-200604000-00006.", "ArticleIdList": ["10.1097/00004691-200604000-00006", "16612226"]}, {"Citation": "Klem GH, L\u00fcders HO, Jasper HH, Elger C. The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999;52:3\u20136.", "ArticleIdList": ["10590970"]}, {"Citation": "Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 2):ii16\u2013ii22.", "ArticleIdList": ["PMC1765695", "15961863"]}, {"Citation": "You Y, Klistorner A, Thie J, Gupta VK, Graham SL. Axonal loss in a rat model of optic neuritis is closely correlated with visual evoked potential amplitudes using electroencephalogram-based scaling. Invest Ophthalmol Vis Sci. 2012;53(7):3662. doi: 10.1167/iovs.12-9843.", "ArticleIdList": ["10.1167/iovs.12-9843", "22723598"]}, {"Citation": "Li P, Yang Y. Pattern reversal visual evoked potentials analysis in patients with noninsulin-dependent diabetes mellitus. Hunan Yi Ke Da Xue Xue Bao. 2001;26(3):283\u2013284.", "ArticleIdList": ["12536710"]}, {"Citation": "Atilla H, Tekeli O, Ornek K, Batioglu F, Elhan AH, Eryilmaz T. Pattern electroretinography and visual evoked potentials in optic nerve diseases. J Clin Neurosci. 2006;13(1):55\u201359. doi: 10.1016/j.jocn.2005.02.007.", "ArticleIdList": ["10.1016/j.jocn.2005.02.007", "16410198"]}, {"Citation": "Karlica D, Galetovi\u0107 D, Ivanisevi\u0107 M, Skrabi\u0107 V, Znaor L, Jurisi\u0107 D. Visual evoked potential can be used to detect a prediabetic form of diabetic retinopathy in patients with diabetes mellitus type I. Coll Antropol. 2010;34(2):525\u2013529.", "ArticleIdList": ["20698126"]}, {"Citation": "Izadi M, Kheirjou R, Mohammadpour R, et al. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes Metab Syndr. 2019;13(1):822\u2013825. doi: 10.1016/j.dsx.2018.11.060.", "ArticleIdList": ["10.1016/j.dsx.2018.11.060", "30641815"]}, {"Citation": "Peralta C, Le\u00f3n OS, Xaus C, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res. 1999;31(3):191\u2013196. doi: 10.1080/10715769900300741.", "ArticleIdList": ["10.1080/10715769900300741", "10499775"]}, {"Citation": "Pozzessere G, Rizzo PA, Valle E, et al. A longitudinal study of multimodal evoked potentials in diabetes mellitus. Diabetes Res. 1989;10(1):17\u201320.", "ArticleIdList": ["2758737"]}, {"Citation": "Lanting P, Strijers RL, Bos JE, Faes TJ, Heimans JJ. The cause of increased pupillary light reflex latencies in diabetic patients: the relationship between pupillary light reflex and visual evoked potential latencies. Electroencephalogr Clin Neurophysiol. 1991;78(2):111\u2013115. doi: 10.1016/0013-4694(91)90110-P.", "ArticleIdList": ["10.1016/0013-4694(91)90110-P", "1704833"]}, {"Citation": "B\u00e1rtek L, Gat'kov\u00e1 A, Rybka J, Kalita Z, Smecka Z. Zrakov\u00e9 evokovan\u00e9 potenci\u00e1ly u diabetik\u016f [Visual evoked potentials in diabetics] Cesk Oftalmol. 1989;45(3):192\u2013196.", "ArticleIdList": ["2743440"]}, {"Citation": "Papakostopoulos D, Hart JC, Corrall RJ, Harney B. The scotopic electroretinogram to blue flashes and pattern reversal visual evoked potentials in insulin dependent diabetes. Int J Psychophysiol. 1996;21(1):33\u201343. doi: 10.1016/0167-8760(95)00040-2.", "ArticleIdList": ["10.1016/0167-8760(95)00040-2", "8839122"]}, {"Citation": "Fierro B, Brighina F, Cardella F, et al. Multievoked potentials in type I diabetic patients: one year follow-up study. Electromyogr Clin Neurophysiol. 1999;39(6):337\u2013344.", "ArticleIdList": ["10499203"]}, {"Citation": "Gregori B, Gali\u00e9 E, Pro S, Clementi A, Accornero N. Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy. Neurol Sci. 2006;27(5):323\u2013327. doi: 10.1007/s10072-006-0704-x.", "ArticleIdList": ["10.1007/s10072-006-0704-x", "17122941"]}, {"Citation": "Lopes de Faria JM, Katsumi O, Cagliero E, Nathan D, Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol. 2001;239(9):643\u2013648. doi: 10.1007/s004170100268.", "ArticleIdList": ["10.1007/s004170100268", "11688662"]}, {"Citation": "Collier A, Mitchell JD, Clarke BF. Visual evoked potential and contrast sensitivity function in diabetic retinopathy. Br Med J (Clin Res Ed) 1985;291(6490):248. doi: 10.1136/bmj.291.6490.248.", "ArticleIdList": ["10.1136/bmj.291.6490.248", "PMC1416861", "3926140"]}, {"Citation": "G\u00fcrb\u00fcz G, Edizer S, \u00dcnalp A, Nalbanto\u011flu \u00d6, Tun\u00e7 S, et al. The evaluation of pattern-reversal visual evoked potentials in children with type 1 diabetes mellitus. Iran J Pediatr. 2019;29(1):e80278."}, {"Citation": "Ponte F, Giuffr\u00e8 G, Anastasi M, Lauricella M. Involvment of the visual evoked potentials in type I insulin-dependent diabetes. Metab Pediatr Syst Ophthalmol. 1986;9(2\u20134):77\u201380.", "ArticleIdList": ["3452012"]}, {"Citation": "Martinelli V, Filippi I, Meschi F, Pozza G, Canal N, Comi GJ. Electrophysiological study of optic pathways in insulin dependent diabetes mellitus. Clin Vis Sci. 1991;6(6):437\u2013443."}, {"Citation": "Martinelli V, Piatti PM, Filippi M, et al. Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients. Acta Diabetol. 1992;29(1):34\u201337. doi: 10.1007/BF00572827.", "ArticleIdList": ["10.1007/BF00572827", "1520904"]}, {"Citation": "Ponte F, Anastasi M, Lauricella M, Bompiani GD. Optic pathway conduction in insulin-dependent diabetics. Doc Ophthalmol. 1986;63(4):313\u2013319. doi: 10.1007/BF00220221.", "ArticleIdList": ["10.1007/BF00220221", "3803162"]}, {"Citation": "Sartucci F, Tognoni G, Guerrini V. Combined use of pattern electroretinograms and visual evoked potentials in evaluation of early visual system involvement in type I diabetic children and adolescents. It J Clin Neurophysiol. 1993;2:10\u201324."}, {"Citation": "Parisi V, Uccioli L, Parisi L, et al. Neural conduction in visual pathways in newly-diagnosed IDDM patients. Electroencephalogr Clin Neurophysiol. 1998;108(5):490\u2013496. doi: 10.1016/S0168-5597(98)00026-4.", "ArticleIdList": ["10.1016/S0168-5597(98)00026-4", "9780019"]}, {"Citation": "Holder GE. The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes. Eye (Lond) 1997;11(Pt 6):924\u2013934. doi: 10.1038/eye.1997.231.", "ArticleIdList": ["10.1038/eye.1997.231", "9537157"]}, {"Citation": "Celesia GG, Kaufman D, Cone SB. Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve. Arch Neurol. 1986;43(12):1247\u20131252. doi: 10.1001/archneur.1986.00520120031012.", "ArticleIdList": ["10.1001/archneur.1986.00520120031012", "3778259"]}, {"Citation": "Celesia GG, Kaufman D. Pattern ERGs and visual evoked potentials in maculopathies and optic nerve diseases. Invest Ophthalmol Vis Sci. 1985;26(5):726\u2013735.", "ArticleIdList": ["3997422"]}, {"Citation": "Trick GL, Burde RM, Gordon MO, Kilo C, Santiago JV. Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials. Doc Ophthalmol. 1988;70(1):19\u201328. doi: 10.1007/BF00154732.", "ArticleIdList": ["10.1007/BF00154732", "3229290"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "27"}, {"Year": "2023", "Month": "6", "Day": "16"}, {"Year": "2023", "Month": "6", "Day": "27", "Hour": "1", "Minute": "7"}, {"Year": "2023", "Month": "6", "Day": "27", "Hour": "1", "Minute": "6"}, {"Year": "2023", "Month": "6", "Day": "26", "Hour": "23", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["37365632", "PMC10291751", "10.1186/s13098-023-01114-w", "10.1186/s13098-023-01114-w"]}}], "PubmedBookArticle": []}